JOHNNY K CHANG MD NPI 1366465304

NPI Information

  • NPI: 1366465304
  • Provider Name: JOHNNY K CHANG, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 16133 VENTURA BLVD
    STE 470
    ENCINO, CA
    ZIP 91436
  • Phone: (818) 981-3818

Map and Directions

Get Directions

NPI Details

Johnny K Chang, MD is a hematology and oncology internal medicine in Encino, CA with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Johnny K Chang, MD NPI is 1366465304. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

16133 VENTURA BLVD
STE 470
ENCINO, CA
ZIP 91436-402
Phone: (818) 981-3818
Fax: (818) 784-3106

The NPI 1366465304 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Folic acid level, serum (HCPCS:82746)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Blood test, clotting time (HCPCS:85610)
  • Red blood count, automated test (HCPCS:85045)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Bilirubin level, direct (HCPCS:82248)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)

The enumeration date for this NPI number is 7/25/2006 and was last updated on 6/26/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyA70618CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100A786180MEDICAIDCALIFORNIA
2H96166MEDICARE UPIN
3WA70618AMEDICARE ID-TYPE UNSPECIFIEDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.